IL-23IL-23

Back to Disease

May 2026

Journal Club Review: SOLSTICE Publication

April 2026

Journal Club Review: APEX Publication

February 2026

Medication Review: What is the Safety and Efficacy Profile of Guselkumab in Juvenile Psoriatic Arthritis?

April 2026

Journal Club Review: DISCOVER-2 Severe PsA Publication

February 2026

Medication Review: Anti-Drug Antibody Development With Guselkumab in Psoriasis, PsA & IBD

February 2026

Medication Review: Laboratory Monitoring Recommendations for Guselkumab in PSO, PsA, and IBD

February 2026

Medication Review: Safety and Efficacy of Guselkumab in the Treatment of CD and UC

January 2026

Journal Club Review: Guselkumab Binds To CD64+ IL-23–Producing Myeloid Cells to Neutralize IL-23 Signals

January 2026

Medication Review: What is the Safety and Efficacy Profile of Guselkumab in Juvenile Psoriatic Arthritis?

December 2025

Medication Review: Describe the Dual Mechanism of Action of Guselkumab

sectionimg

dotsimg

Download the app and start using it now.

Download on the App Store

GET IT ON Google Play